Gyros
About:
Gyros is specialized in the production of automated micro-immunoassays for therapeutic protein development.
Website: http://www.gyros.com
Twitter/X: gyrosassays
Top Investors: 3i Group, Industrifonden, HealthCap, Investor AB, Karolinska
Description:
Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.
$39.9M
Less than $1M
Monmouth Junction, New Jersey, United States
2000-01-01
information(AT)gyros.com
Maris Hartmanis
51-100
2009-07-06
Private
© 2025 bioDAO.ai